Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Shares Outstanding (Weighted Average) (2016 - 2025)

Marimed has reported Shares Outstanding (Weighted Average) over the past 15 years, most recently at $390.1 million for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 2.9% to $390.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $390.1 million through Dec 2025, up 2.9% year-over-year, with the annual reading at $390.1 million for FY2025, 2.9% up from the prior year.
  • Shares Outstanding (Weighted Average) was $390.1 million for Q4 2025 at Marimed, down from $392.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $392.6 million in Q3 2025 and troughed at $305.2 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $360.2 million (2023), against an average of $355.9 million.
  • Year-over-year, Shares Outstanding (Weighted Average) skyrocketed 32.22% in 2021 and then rose 1.96% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $326.5 million in 2021, then rose by 3.44% to $337.7 million in 2022, then grew by 7.61% to $363.4 million in 2023, then increased by 4.33% to $379.2 million in 2024, then grew by 2.9% to $390.1 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Shares Outstanding (Weighted Average) are $390.1 million (Q4 2025), $392.6 million (Q3 2025), and $389.9 million (Q2 2025).